Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PReoperative Dose Escalated Stereotactic radioSurgery for Resectable Brain Metastases (PRESS)

NCT07802353 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.

NCT NCT07802353
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07802353 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PReoperative Dose Escalated Stereotactic radioSurgery for Resectable Brain Metastases (PRESS)
Lead sponsor
Memorial Sloan Kettering Cancer Center
Phase
Not applicable
Overall status
Recruiting
Start date
August 28, 2026
Completion date
August 31, 2028
Enrollment
50 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

brain metastasases